Proteocyte Diagnostics
PrivateLast Round
Seed
Sep 10, 2014
Company Overview
Proteocyte Diagnostics operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Seed round in September 2014.
Proteocyte Diagnostics is a biotechnology company that develops and commercializes molecular diagnostics tests, including its flagship oral cancer risk prediction test, Straticyte.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proteocyte Diagnostics Comparables
Compare Proteocyte Diagnostics with similar companies based on industry and business-model similarity.
No comparables are published for Proteocyte Diagnostics. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Proteocyte Diagnostics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Proteocyte Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wilfrid Laurier University | Seed |
| MaRS Discovery District | Seed |
| Freycinet Ventures | Seed |
| Golden Triangle Angel Network | Seed |
| Ontario Centre of Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 44% MoM to 10.9K.
- May 17, 2026
Monthly visitors increased 177% MoM, reaching 7.6K.
For institutional investors. Book with your work email.
Proteocyte Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Proteocyte Diagnostics's valuation, stock price, and market status.
Is Proteocyte Diagnostics a public or private company?
Proteocyte Diagnostics is a private company.
What is the current stock price of Proteocyte Diagnostics?
Proteocyte Diagnostics is a private company, so its shares have no public market price. Caplight tracks Proteocyte Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Proteocyte Diagnostics worth (valuation)?
Valuation information for Proteocyte Diagnostics is not publicly available.
Can I buy Proteocyte Diagnostics stock?
Proteocyte Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Proteocyte Diagnostics's last funding round?
Proteocyte Diagnostics's most recent funding round was Seed on September 10, 2014.
Who are the main investors in Proteocyte Diagnostics?
Key investors in Proteocyte Diagnostics include Wilfrid Laurier University, MaRS Discovery District, Freycinet Ventures, Golden Triangle Angel Network, Ontario Centre of Innovation.
Will Proteocyte Diagnostics IPO soon?
No public IPO plans have been announced for Proteocyte Diagnostics.
How can I track Proteocyte Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Proteocyte Diagnostics's shares on secondary markets.